Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 1,513–1,520 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Edesa Biotech Inc. Paridiprubart - (EB05) COVID-19, Acute Respiratory Distress Syndrome (ARDS) Phase 2/3 Data Released Intravenous COVID-19
Edesa Biotech Inc. EB01 Allergic contact dermatitis (ACD) Phase 2b Ongoing Topical Immunology
Edesa Biotech Inc. EB06 Vitiligo Phase 2 Trial Completed Intravenous N/A
Edgewise Therapeutics Inc. EDG-5506 - (FOX) Dystrophinopathies including Duchenne Muscular Dystrophy in children and adolescent boys Phase 2 Ongoing Oral Genetic Disorder
Edgewise Therapeutics Inc. EDG-7500 - (CIRRUS-HCM) Hypertrophic Cardiomyopathy (HCM) Phase 2 Data Released Oral Cardiology
Edgewise Therapeutics Inc. EDG-5506 - (LYNX) Duchenne Muscular Dystrophy (DMD) Phase 2 Trial Completed oral Genetic Disorder
Edgewise Therapeutics Inc. Sevasemten - (MESA) Becker and Duchenne Muscular Dystrophies Phase 2 Data Released Oral Genetic Disorder
Edgewise Therapeutics Inc. Sevasemten (EDG-5509) - (GRAND CANYON) Becker and Duchenne muscular dystrophy Phase 2 Ongoing Oral Genetic Disorder
1…188189190191192…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.